Literature DB >> 26259751

Treatment and Prognosis of Rare Breast Cancers.

Alicia M Terando1, Doreen M Agnese, Dennis R Holmes.   

Abstract

Management algorithms for invasive and non-invasive ductal and lobular breast carcinomas are well-established. Because of their very nature, rare histologic types of primary breast cancers are not represented in practice guidelines and thus present a challenge to the practicing clinician who must make recommendations for surgical treatment, axillary staging, and adjuvant therapy, as well as counsel patients as to their expected disease course and prognosis. Herein, case reports and published series of rare types of primary breast cancer including adenoid cystic, mucoepidermoid, metaplastic, squamous, neuroendocrine, encysted papillary, and micropapillary types will be reviewed to provide a basis for treatment planning for patients presenting with these rare primary breast malignancies.

Entities:  

Mesh:

Year:  2015        PMID: 26259751     DOI: 10.1245/s10434-015-4748-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

1.  A rare case of invasive micropapillary carcinoma of the breast.

Authors:  Georgios-Ioannis Verras; Francesk Mulita; Levan Tchabashvili; Ioanna-Maria Grypari; Sofia Sourouni; Evangelia Panagodimou; Maria-Ioanna Argentou
Journal:  Prz Menopauzalny       Date:  2022-02-21

Review 2.  Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis.

Authors:  Georgios-Ioannis Verras; Levan Tchabashvili; Francesk Mulita; Ioanna Maria Grypari; Sofia Sourouni; Evangelia Panagodimou; Maria-Ioanna Argentou
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-03-12

3.  Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors.

Authors:  Paul Savage; Alain Pacis; Hellen Kuasne; Leah Liu; Daniel Lai; Adrian Wan; Matthew Dankner; Constanza Martinez; Valentina Muñoz-Ramos; Virginie Pilon; Anie Monast; Hong Zhao; Margarita Souleimanova; Matthew G Annis; Adriana Aguilar-Mahecha; Josiane Lafleur; Nicholas R Bertos; Jamil Asselah; Nathaniel Bouganim; Kevin Petrecca; Peter M Siegel; Atilla Omeroglu; Sohrab P Shah; Samuel Aparicio; Mark Basik; Sarkis Meterissian; Morag Park
Journal:  Commun Biol       Date:  2020-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.